Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03124771 · ClinicalTrials.gov registry record · NA
Accuracy of Noninvasive Hemoglobin Pulse Oximeter (Rainbow Resposable Adhesive Sensors)
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT03124771 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 132 participants.
The verdict
NCT03124771, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
In this study, the concentration of hemoglobin within the subject's blood will be reduced in a controlled manner by administering fluids intravenously. The accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.
Interventions
- DEVICE Rainbow Resposable Adhesive Sensors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2011-12-27 |
| Est. Completion | 2012-04-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03124771
The ClinicalTrials.gov registry entry for NCT03124771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rainbow Resposable Adhesive Sensors is the first listed.
NCT03124771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03124771 about?
NCT03124771 is a clinical study titled "Accuracy of Noninvasive Hemoglobin Pulse Oximeter (Rainbow Resposable Adhesive Sensors)". In this study, the concentration of hemoglobin within the subject's blood will be reduced in a controlled manner by administering fluids intravenously. The accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.
What is the current status of trial NCT03124771?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2011-12-27. Estimated completion is 2012-04-03.
What interventions are being tested in trial NCT03124771?
The interventions under investigation include: Rainbow Resposable Adhesive Sensors (DEVICE).
Who is sponsoring clinical trial NCT03124771?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.